Measles antibody: Reevaluation of protective titers

Journal of Infectious Diseases

Volumn 162, Issue 5, 1990, Pages 1036-1042

  Chen, Robert T ^a,b   Markowitz, Lauri E ^a,b   Albrecht, Paul ^a,b   Stewart, John A ^a,b   Mofenson, Lynne M ^a,b   Orenstein, Walter A ^a,b,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c Division of Communicable Disease Control   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CHILD; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MEASLES VIRUS; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; BOSTON; DISEASE OUTBREAKS; HUMAN; IMMUNOENZYME TECHNIQUES; MEASLES; MEASLES VIRUS; NEUTRALIZATION TESTS; VACCINATION;

EID: 0025089766     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/162.5.1036     Document Type: Article

References (41)

1. Panum PL. Observations made during the epidemic of measles on the Faroe Islands in the year 1846. New York: American Public Health Association, 1940:52
2. Pelner L. Repeated attacks of measles. Am J Dis Child 1941;62:358–361
3. Krugman S. Further-attenuated measles vaccine: characteristics and use. Rev Infect Dis 1983;5:477–481
4. Enders-Ruckle G. Methods of determining immunity, duration and character of immunity resulting from measles. Arch Virusforsch 1965;16:182–207
5. Stokes J, Reilly CM, Buynak EB, Hilleman MR. Immunologic studies of measles. Am J Hyg 1961;74:293–303
6. Neumann PW, Weber JM, Jessamine AG, O’Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol 1985; 2:296–298
7. Brunell PA, Weigle K, Murphy MD, Shehab Z, Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983;250:1409–1412
8. Lievens AW, Brunell PAS. Specific IgM enzme-linked immunosorbent assay (ELISA) for confirming the diagnosis of measles. J Clin Microbiol 1986;24:391–394
9. Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981;3:251–260
10. Weigle KA, Murphy MD, Brunell PA. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus. J Clin Microbiol 1984;19:376–379
11. Orenstein WA, Herrmann KL, Albrecht P, Bernier R, Holmgreen P, Bart KJ, Himnan AR. Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Stand 1986;65:75–83
12. Albrecht P, Ennis FA, Saltzman EJ, Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanisms of measles vaccine failure. J Pediatr 1977;91:715–718
13. Sato H, Albrecht P, Reynolds DW. Transfer of measles, mumps, and rubella antibodies from mother to infant: its effect on measles, mumps, and rubella immunization. Am J Dis Child 1979;133:1240–1243
14. Orenstein WA, Albrecht P, Herrmann KL, Bernier R, Bart KJ, Rovira E. Evaluation of low levels of measles antibody: the plaque neutralization test as a measure of prior exposure to measles virus. J Infect Dis 1987;155:146–149
15. Centers for Disease Control. Classification of measles cases and categorization of measles elimination programs. MMWR 1983;31:701–711
16. Bellanti JA, ed. Immunology. 3rd ed. Philadelphia: W. B. Saunders, 1985:566
17. Ndikuyeze A, Munoz A, Stewart J, Modlin J, Heymann D, Herrmann KL, Polk BF. Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol 1988;17:448–455
18. Schaffner W, Schluederberg AES, Byrne EB. Clinical epidemiology of sporadic measles in a highly immunized population. N Engl J Med 1988;279:783–789
19. Cherry JD, Feigin RD, Lobes LA, Shackelford PG. A typical measles in children previously immunized with attenuated measles virus vaccine. Pediatrics 1972;50:712–717
20. Smith FR, Curran AS, Raciti A, Black FL. Reported measles in persons immunologically primed by prior vaccination. J Pediatr 1982; 101:391–393
21. Linnemann CC, Rotte TC, Schiff GM. A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol 1972;95:238–246
22. Reyes AM, DeBorrero MB, Roa J, Bergonzoli G, Saravia NG. Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987;6:848–851
23. Mathias RC, Meekison WG, Arcand TA, Schecter MT. The role of secondary vaccine failures in measles outbreaks. Am J Public Health 1989;79:475–478
24. Cherry JD, Feigin RD, Shackelford PG, Hinthorn DR, Schimidt RR. A clinical and serological study of 103 children with measles vaccine failure. J Pediatr 1973;82:802–808
25. Schluederberg A. Modification of immune response by previous experience with measles. Arch Virusforsch 1965;16:347–350
26. Cremer NE, Cossen CK, Shell G, Diggs J, Gallo D, Schmidt NJ. Enzyme immunoassay versus plaque neutralization and other methods for determination of immune status to measles and varicella-zoster viruses and versus complement fixation for serodiagnosis of infection with those viruses. J Clin Microbiol 1985;21:869–874
27. Gustafson TL, Lievens AW, Brunell PA, Moellenberg RG, Buttery CMG, Sehulster LM. Measles outbreak in a fully immunized secondaryschool population. N Engl J Med 1987;316:771–774
28. Sabin AB, Arechiga AF, Fernandez de Castro J, Sever JL, Madden DL, Shekarchi I, Albrecht P. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 1983;49:2651–2662
29. Sabin AB, Albrecht P, Takeda AK, Ribeiro EM, Veronesi R. High effectiveness of aerosolized chick embryo fibroblast vaccine in 7-month-old and older infants. J Infect Dis 1985;152:1231–1237
30. Cherry JD, Feigin RD, Lobes LA, Hinthorn DR, Shackelford PG, Shirley RH, Lins RD, Choi SC. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr 1972;81:217–230
31. Linnemann CC, Hegg ME, Rotte TC, Phair JP, Schiff GM. Measles IgM response during reinfection of previously vaccinated children. J Pediatr 1973; 82:798–801
32. Nagy G, Kosa S, Takatsy S, Koller M. The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981. J Med Virol 1984;13:93–103
33. Krugman S, Giles JP, Friedman H, Stone S. Studies on immunity to measles. J Pediatr 1965:66:471–488
34. Wintermeyer L, Myers MG. Measles in a partially immunized community. Am J Public Health 1979;69:923–927
35. Brandling-Bennett AD, Landrigan PJ, Baker EL. Failure of vaccinated children to transmit measles. JAMA 1973;224:616–618
36. Frank JA, Orenstein WA, Bart KJ, Bart SW, E1-Tantawy N, Davis RM, Hinman AR. Major impediments to measles elimination: the modern epidemiology of an ancient disease. Am J Dis Child 1985; 139:881–888
37. Markowitz LE, Preblud SR, Orenstein WA, Rovira EZ, Adams NC, Hawkins GE, Hinman AR. Patterns of transmission in measles outbreaks in the United States, 1985–1986. N Engl J Med 1989;320:75–81
38. Committee on Infectious Diseases, American Academy of Pediatrics. Measles: reassessment of the current immunization policy. Pediatrics 1989;84:1110–1113
39. Centers for Disease Control. Measles prevention: recommendation of the Immunization Practices Advisory Committee (ACIP). MMWR 1989;38(suppl 9):1–18
40. Deseda-Tous J, Cherry JD, Spencer MJ, Welliver RC, Boyer KM, Dudley JP, Zahradnik JM, Krause PJ, Walbergh EW. Measles revaccination: persistence and degree of antibody titer by type of immune response. Am J Dis Child 1978;132:287–290
41. Markowitz LE, Preblud SR, Fine PEM, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 1990;9:101–110